Leading newspapers, including the Wall St. Journal and New York Times, misunderstand the strategy behind Pfizer’s proposed purchase of Hospira. Here’s what the Journal had to say: Pfizer Inc. said ...

This week's roundup of deals worth $1 billion or more includes Am Law firms working on a $15.2 billion pharmaceutical transaction between Pfizer and Hospira; a $10.54 billion telecom deal between ...

NEW YORK, Feb 5 (Reuters) - Pfizer Inc's $15 billion deal to buy Hospira Inc will allow the largest U.S. drugmaker to benefit from specialty generic medicines that are commanding far higher prices ...

Pfizer has updated its full year sales and earnings forecast to include the impact of its recent acquisition of biosimilar drugmaker Hospira. Specifically, Pfizer thinks it will generate at least ...

Following the end of patent exclusivity on Pfizer's blockbuster cholesterol drug Lipitor in 2012, the company has been hunting for ways to recoup lost sales. So far, that hunt has come up short.

Pfizer, a multinational pharmaceutical corporation headquartered in New York City, will acquire Hospira, a Lake Forest, Ill.-based global pharmaceutical and medical device company, for $90 a share in ...

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

A US Food and Drug Administration (FDA) inspection at the McPherson, KS plant of Pfizer’s Hospira business revealed seven repeat FDA Form 483 citations dating back to 2012. FDA investigators conducted ...

The problem this time involves nearly 4700 infusion pumps that may have faulty alarms. Chris Newmarker FDA recently posted a Class I designation for a Hospira recall involving nearly 4700 Plum A+ and ...

In a 32-page US Food and Drug Administration (FDA) Form 483, 11 citations revealed manufacturing and quality control issues at the Hospira Healthcare India facility in Tamil Nadu. FDA visited the ...